If the rich turn their back on a stock, is staying long a poor decision?» Read More
Some of the names on the move ahead of the open.
Canadian drugmaker Valeant Pharmaceuticals International raised the cash component of its offer for Botox-maker Allergan by $10 per share.
Facebook has asked the European Union to launch an antitrust review of its $16 billion purchase of social messaging service WhatsApp.
General Electric has improved its offer for French train and turbine maker Alstom, with a pledge to create 1,000 jobs in France, sources said.
Toll Brothers, the largest U.S. luxury home builder, said quarterly profit more than doubled as it sold more homes at higher prices.
The "Fast Money" traders share their final trades of the day.
Looking at the price action in Bank of America on Tuesday, Jim Cramer thinks financials may be coming back into favor on Wall Street.
Fundamentals appear positive. However, if this technical analysis is right, bulls are in trouble.
Some economists expect inflation to begin building to a point where even the Federal Reserve cannot deny.
With the market moving higher Tuesday and the S&P hitting a new high, two pros weigh in on how to position your portfolio.
So far, Citigroup's second-quarter trading revenue has dropped 20 percent to 25 percent, said John Gerspach, the bank's chief financial officer
As U.S. indexes are testing highs, retail investors are jumping back into the risky world of penny stocks faster than ever.
The long-predicted "great rotation" out of bonds has fizzled, with funds headed back into fixed income, frustrating forecasts for higher yields.
The market is still waiting for news on Alibaba, but there are signs of life in the disappoinitng IPO market.
Check out which companies are making headlines after the bell Tuesday: Workday, Wet Seal, Cerner & more
IntercontinentalExchange is pressing ahead with a listing of European exchange Euronext, which could achieve a valuation of at least $2.1 billion.
Amid a flurry of IPOs on global stock markets, investors may be struggling to catch their breath as "deal fatigue" sets in, analysts said.
Looking at recent earnings, Jim Cramer has noticed a somewhat common theme among those companies doing well.
When a new company comes public Jim Cramer often talks about bloodlines. But this time he means it literally.
Tuesday's durable goods report will give us an important indication of where the economy's heading.
Get the best of CNBC in your inbox